BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28638382)

  • 21. Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia.
    Needham E; Zandi MS
    J Neurol; 2014 Oct; 261(10):2037-42. PubMed ID: 25182699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity and degeneracy: T cell recognition in CNS autoimmunity.
    Zhou D; Hemmer B
    Mol Immunol; 2004 Feb; 40(14-15):1057-61. PubMed ID: 15036910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An autoimmunity odyssey: how autoreactive T cells infiltrate into the CNS.
    Kawakami N; Bartholomäus I; Pesic M; Mues M
    Immunol Rev; 2012 Jul; 248(1):140-55. PubMed ID: 22725959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of the immune system.
    Medina KL
    Handb Clin Neurol; 2016; 133():61-76. PubMed ID: 27112671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis: therapeutic implications.
    Mastorodemos V; Ioannou M; Verginis P
    Neuroimmunomodulation; 2015; 22(3):181-95. PubMed ID: 24852748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
    Pritsch O; Maloum K; Dighiero G
    Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system.
    Pender MP
    J Neuroimmunol; 2007 Nov; 191(1-2):26-38. PubMed ID: 17931708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
    Wu D; Wang J; Pae M; Meydani SN
    Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF; Martin R
    Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
    Samoilova EB; Horton JL; Hilliard B; Liu TS; Chen Y
    J Immunol; 1998 Dec; 161(12):6480-6. PubMed ID: 9862671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease.
    Greer JM; Broadley S; Pender MP
    Front Immunol; 2017; 8():514. PubMed ID: 28533776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network.
    Weathington NM; Blalock JE
    Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models.
    Ujiie H; Shimizu H
    Exp Dermatol; 2012 Dec; 21(12):901-5. PubMed ID: 23016514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auto-reactive T cells revised. Overestimation based on methodology?
    Thorlacius-Ussing G; Sørensen JF; Wandall HH; Pedersen AE
    J Immunol Methods; 2015 May; 420():56-9. PubMed ID: 25825374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of T cell apoptosis in nervous system autoimmunity.
    Comi C; Fleetwood T; Dianzani U
    Autoimmun Rev; 2012 Dec; 12(2):150-6. PubMed ID: 22504460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
    Friese MA; Fugger L
    Brain; 2005 Aug; 128(Pt 8):1747-63. PubMed ID: 15975943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell vaccination as an immunotherapy for autoimmune diseases.
    Zhang J
    Cell Mol Immunol; 2004 Oct; 1(5):321-7. PubMed ID: 16285890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tertiary Lymphoid Organs in Central Nervous System Autoimmunity.
    Mitsdoerffer M; Peters A
    Front Immunol; 2016; 7():451. PubMed ID: 27826298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.